OtherCase Studies
Session 4.2 Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
Meisam Bakhshayeshi and Rachel Specht
PDA Journal of Pharmaceutical Science and Technology August 2016, pdajpst.2016.006965; DOI: https://doi.org/10.5731/pdajpst.2016.006965
Meisam Bakhshayeshi
1 Biogen;
Rachel Specht
2 Genentech, a Member of the Roche Group
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
Session 4.2 Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
Meisam Bakhshayeshi, Rachel Specht
PDA Journal of Pharmaceutical Science and Technology Aug 2016, pdajpst.2016.006965; DOI: 10.5731/pdajpst.2016.006965
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.